Why Are Owens & Minor Shares Surging Today?

Loading...
Loading...
  • Owens & Minor Inc OMI reported adjusted EPS of $0.74 in Q3, lower than $0.81 a year ago but ahead of the consensus of $0.55.
  • However, revenue for the quarter increased to $2.502 billion from $2.188 billion last year, better than the consensus estimate of $2.46 billion.
  • "In our Global Products segment, the advantage of having Americas owned and operated manufacturing facilities enables us to consistently provide our Halyard branded medical-grade products with minimal impact from global supply chain disruptions," said Edward Pesicka, President & CEO.
  • Owens & Minor reported a higher cost of goods sold to $2.2 billion, resulting in margin contraction, with the gross margin down to 13.1% from 15.7% and operating margin falling from 3.5% to 2.5%.
  • Guidance: The company has narrowed its full-year adjusted EPS to $3.90 - $4.10 (consensus $3.89) from $3.75 - $4.25.
  • OMI sees adjusted EBITDA of $475 million - $500 million, compared to earlier guidance of $450 million - $500 million.
  • The company also reaffirmed its previously announced 2022 guidance.
  • Price Action: OMI shares are up 15.4% at $42.69 during the market session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLong IdeasNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...